Data / Form D filings / OrisDx Inc.
OrisDx Inc.: Form D filing
OrisDx Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2025. The latest, on July 16, 2025, reports $2.8 million sold of a $4 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 363 E WACKER DRIVE, UNIT 2703, Chicago, IL, 60601
- Phone
- (630) 800-7379
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2074140
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2025 | New notice | $4,000,000 | $2,844,388 | $1,155,612 | 25 | May 23, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harald Steltzer | Executive Officer, Director | |
| Evgeny Izmchenko | Director | |
| Patrick Conniff | Executive Officer | |
| Nishant Agrawal | Director |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OrisDx Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.